Intratypic characterization of poliovirus type 1 isolates

Area of Science:

• Virology
• Epidemiology
• Immunology

Background:

• Poliovirus type 1 circulates globally, posing a significant public health challenge.
• Oral poliovirus vaccine (OPV) is a primary tool for polio eradication.
• Understanding poliovirus strain diversity is crucial for effective vaccination strategies.

Purpose of the Study:

• To serodifferentiate poliovirus type 1 strains isolated from different epidemiological settings.
• To investigate the efficacy of OPV in displacing wild poliovirus strains.
• To characterize antigenic variants of poliovirus.

Main Methods:

• Serodifferentiation of 607 poliovirus type 1 isolates using strain-specific antisera and monoclonal antibodies.
• Analysis of isolates from epidemic, endemic, and vaccinated areas.
• Epitope mapping of detected antigenic variants using monoclonal antibodies.

Main Results:

• Both vaccine-like and non-vaccine-like poliovirus strains were isolated from an epidemic area (Marathwada) with mass OPV vaccination.
• Only non-vaccine-like strains were found in an endemic area (Bombay).
• Despite high OPV coverage (93%) in a previously vaccinated area (Emmaneshwaram), non-vaccine-like strains predominated, indicating OPV insufficiency in displacing wild virus.
• A small number of antigenic variants were detected, with higher frequency following paralytic poliomyelitis outbreaks.

Conclusions:

• Routine OPV immunization alone may not be sufficient to eliminate wild poliovirus.
• The emergence and circulation of non-vaccine-like strains and antigenic variants highlight the need for ongoing surveillance and potentially adapted vaccine strategies.
• Mass vaccination campaigns following outbreaks may increase the frequency of antigenic variants.